Document is current
Any future updates will be listed below
-
Authors
Yamada, Toshiki
Nakamura, Nobuhiko https://orcid.org/0000-0003-1682-7777
Goto, Hideko
Hara, Takeshi
Kasahara, Senji
Fukuno, Kenji
Sawada, Michio
Nakamura, Hiroshi
Hayase, Naoki
Goto, Takayuki
Suzaki, Tomomi
Fujita, Kei
Lee, Shin
Kanemura, Nobuhiro
Shimizu, Masahito
Tsurumi, Hisashi
-
Funding
Funding for this research was provided by:
Gifu University
- License Information
-
More Information
Article History
Received: 13 July 2025
Accepted: 2 September 2025
First Online: 10 October 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Gifu University Graduate School of Medicine (approval number: 2022 − 221).
: Due to the retrospective nature of the study and the use of anonymized data, the requirement for informed consent was waived by the ethics committee.
: Nobuhiko Nakamura received honoraria from Chugai Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Sanofi, Novartis, MSD K.K., Sumitomo Pharma Co., Ltd., Nippon Kayaku Co., Ltd., Nippon Shinyaku Co., Ltd., Meiji Seika Pharma Co., Ltd., and AstraZeneca K.K. The remaining authors have no competing interests.
